Drug importation would harm Americans' health and jeopardize future developments in medical science.

Knowing where all our ingredients come from is the first step toward improving drug quality.

The trade in inferior quality medicines kills innocent patients. Perhaps 15 percent of the global drug supply outside of advanced countries is counterfeit, rising in certain markets in parts of Africa and Asia to over 50 percent. But counterfeits are not the only low-quality drugs on the market.

Americans pay more--often a lot more--for drugs than Canadians and Europeans. That is unfair, but wholesale importation of drugs from these locations isn't the answer.

It is likely that some form of drug reimportation will be approved by the U.S. Congress this year, if not in the next few weeks.

Leading economic and security experts will discuss the trade-offs between trade and security.

Controversies surrounding pharmaceutical patents and trade rules in the WTO

Pharmaceutical patents, drug prices, and parallel imports of drugs from lower-income to higher-income nations have been at the center of some of the most contentious debates in the run-up to Cancun. This panel will analyze the positions of the various protagonists...

The proliferation of low-quality and counterfeit drugs is one of the most pressing problems in delivering life-saving medicines to the world's poorest patients.